Allergan plc Ordinary Shares (AGN): Price and Financial Metrics


Allergan plc Ordinary Shares (AGN)

Today's Latest Price: $190.67 USD

1.15 (0.61%)

Updated Feb 28 6:30pm

Add AGN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AGN Stock Summary

  • Allergan plc's market capitalization of $63,636,561,584 is ahead of 96.73% of US-listed equities.
  • Allergan plc's stock had its IPO on June 22, 1989, making it an older stock than 88.14% of US equities in our set.
  • Over the past twelve months, AGN has reported earnings growth of 760.95%, putting it ahead of 98.12% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Allergan plc, a group of peers worth examining would be COP, LYG, APD, UL, and SNP.
  • Visit AGN's SEC page to see the company's official filings. To visit the company's web site, go to www.allergan.com.
AGN Daily Price Range
AGN 52-Week Price Range

AGN Stock Price Chart More Charts


AGN Price/Volume Stats

Current price $190.67 52-week high $202.21
Prev. close $189.52 52-week low $114.27
Day low $185.41 Volume 4,951,800
Day high $190.68 Avg. volume 2,861,252
50-day MA $192.80 Dividend yield 1.56%
200-day MA $169.83 Market Cap 62.73B

Allergan plc Ordinary Shares (AGN) Company Bio


Allergan plc markets products that provide treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business. The company was founded in 1983 and is based in Parsippany, New Jersey.

AGN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$190.67$452.86 134%

Below please find a table outlining a discounted cash flow forecast for AGN, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Allergan plc ranked in the 72th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 135.5%. As for the metrics that stood out in our discounted cash flow analysis of Allergan plc, consider:

  • As a business, AGN is generating more cash flow than 94.04% of positive cash flow stocks in the Healthcare.
  • Allergan plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • Allergan plc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -5.54. This coverage rate is greater than that of just 7.84% of stocks we're observing for the purpose of forecasting via discounted cash flows.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%130%
1%132%
2%134%
3%137%
4%139%
5%141%

Want more companies with a valuation profile/forecast similar to that of Allergan plc? See NVO, JAZZ, BLFS, HUM, and FMS.


AGN Latest News Stream


Event/Time News Detail
Loading, please wait...

AGN Latest Social Stream


Loading social stream, please wait...

View Full AGN Social Stream

AGN Price Returns

1-mo 2.00%
3-mo 3.48%
6-mo 20.31%
1-year 37.91%
3-year -18.26%
5-year -32.37%
YTD 0.11%
2019 45.82%
2018 -16.88%
2017 -21.09%
2016 -32.80%
2015 21.40%

AGN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full AGN Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7058 seconds.